Psymplicity Healthcare

Updated 28 May 2026

We carried out this assessment as part of our routine monitoring of Psymplicity Healthcare. The assessment took place between 23 and 30 June 2026, including on-site visits on 23 and 24 June and remote evidence gathering on 25, 26 and 30 June. This was the first assessment of this newly registered independent mental health service.

Psymplicity Healthcare registered with the Care Quality Commission on 13 August 2025 to carry out the regulated activity Treatment of Disease, Disorder or Injury (TDDI). The service provides remote assessment, diagnosis and treatment for adults, children and young people accessing neurodevelopmental and mental health pathways, including Autism Spectrum Disorder (ASD), Attention Deficit Hyperactivity Disorder (ADHD) and general psychiatry services. The service also provides ongoing treatment and review appointments, prescribing and psychological therapies, including cognitive behavioural therapy (CBT), trauma-focused therapy, family consultation and eating disorder support where appropriate.

We rated this service as good. No breaches of regulation were identified at this assessment.

The provider had established systems and processes to support the delivery of safe, effective and person-centred care. Clinicians completed structured assessments, considered information from multiple sources and worked collaboratively with other professionals when additional expertise or information was required. The service had arrangements to support safeguarding, risk management and the safe prescribing of medicines.

People were able to access assessments and treatment through clearly defined pathways. Care and treatment recommendations reflected individual circumstances and needs, and clinicians considered the wider impact of people's difficulties when developing recommendations and support options. The provider also worked collaboratively with other organisations to support people who required additional support or onward referral.

Leaders maintained oversight of clinical, operational and organisational risks and used audit findings, complaints, patient feedback and other governance processes to support learning and improvement. Governance arrangements provided oversight of key areas of service delivery and organisational risk, and staff described a supportive and collaborative culture.

However, arrangements for monitoring treatment outcomes and medicine side effects were not yet fully standardised. We also found that documentation relating to consent, capacity and competence was not always recorded consistently. In addition, some governance and reporting arrangements remained under development at the time of the assessment.

Updated 28 May 2026

People consistently described positive experiences of the service. They told us clinicians were professional, knowledgeable and respectful and that they felt listened to throughout their contact with the service.

People described assessments as thorough and said clinicians took time to understand their circumstances, explain findings and discuss recommendations. They felt involved in decisions about their care and treatment and had opportunities to ask questions before decisions were made.

People reported timely access to care and treatment and commented positively on the convenience and flexibility of remote appointments. They said communication was clear, recommendations reflected their individual needs and circumstances, and assessment outcomes helped them better understand their difficulties and access additional support where needed.